申请人:Novo Nordisk A/S
公开号:US06015813A1
公开(公告)日:2000-01-18
The present invention relates to therapeutically active azabicyclic compounds of formula I ##STR1## wherein X, R.sup.1, R.sup.2, R.sup.3, Ar, m and n are defined in the description, a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in treating a disease in the central nervous system caused by malfunctioning of the muscarinic cholinergic system.
本发明涉及公式I的治疗活性的杂环氮化合物:##STR1##其中X,R.sup.1,R.sup.2,R.sup.3,Ar,m和n在说明中定义,以及制备相同的方法和包含该化合物的制药组合物。这些新化合物对于治疗由胆碱能肌动系统功能失调引起的中枢神经系统疾病是有用的。